PUBLISHER: TechSci Research | PRODUCT CODE: 1121072
PUBLISHER: TechSci Research | PRODUCT CODE: 1121072
Global Central Nervous System Therapeutics Market By Drug Class By Application By Route of Administration By End Users By Distribution Channel By Region, Competition Forecast & Opportunities, 2027
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The global central nervous system therapeutics market is anticipated to grow at a strong CAGR during the forecast period, 2023-2027. Factors such as the rise in prevalence of central nervous system disorders and advancements in therapeutics and diagnostics of central nervous system disorders are driving the demand for the global central nervous system therapeutics market. Growing diagnosis rates in developed and emerging economies are presenting a large patient pool that requires treatment. Also, the initiatives by the government authorities, healthcare systems, non-profit organizations, and market players to create awareness about neurological disorders are further expected to support the growth of the global central nervous system therapeutics market in the forecast period.
The global central nervous system therapeutics market is segmented into drug class, application, route of administration, end user, distribution channels, regional distribution, and competitive landscape. Based on application, the market is fragmented into neurovascular diseases, mental health and trauma, neurodegenerative diseases, infectious diseases, cns cancer, and others. Neurodegenerative diseases are expected to capture the highest market share during the forecast period, 2023-2027. The high cost of treatment of neurodegenerative diseases and the increased prevalence of neurodegenerative diseases such as Parkinson's disease, multiple sclerosis, and Alzheimer's disease are driving the segment demand.
North America is expected to dominate the global central nervous system therapeutics market during the forecast period. The presence of key market players in the region and the initiatives taken by market players to develop new technologies are infleuncing the market demand. Also, the rising incidence of mental health conditions and neurological disorders is expected to propel the market demand in the forecast period.
The major market players operating in the global central nervous system therapeutics market are: Eli Lilly and Company Ltd., Merck & Co. Inc., AstraZeneca PLC, Novartis AG, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Biogen Inc., Pfizer Inc., GlaxoSmithKline PLC, Otsuka Holdings Co. Ltd., Johnson & Johnson Services Inc., Sanofi SA, Bristol Myers Squibb Pharmaceuticals Ltd., Bayer AG, Amgen Inc., among others.
Years considered for this report:
- Historical Years: 2017 - 2020
- Base Year: 2021
- Estimated Year: 2022
- Forecast Period: 2023 - 2027
Objective of the Study:
- To analyze and forecast the market size of Global central nervous system therapeutics market from 2017 to 2021.
- To estimate and forecast the market size of Global central nervous system therapeutics market from 2022 to 2027 and growth rate until 2027.
- To classify and forecast global central nervous system therapeutics market based on drug class, application, route of administration, end user, distribution channel, and regional distribution.
- To identify dominant region or segment in the global central nervous system therapeutics market.
- To identify drivers and challenges for global central nervous system therapeutics market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global central nervous system therapeutics market.
- To identify and analyze the profile of leading players operating in global central nervous system therapeutics market.
- To identify key sustainable strategies adopted by market players in global central nervous system therapeutics market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of global central nervous system therapeutics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Central nervous system therapeutics manufacturers, end users, service providers and other stakeholders
- Distributers and suppliers of central nervous system therapeutics and services and other stakeholders
- Organizations, forums, and alliances related to central nervous system therapeutics
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, Global central nervous system therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Market, By Drug Class:
- Analgesics
- Anesthetics
- Anticonvulsants
- Antiepileptics
- Anti-Parkinson Agents
- Others
Market, By Application:
- Neurovascular Diseases
- Mental Health and Trauma
- Neurodegenerative Diseases
- Infectious Diseases
- CNS Cancer
- Others
Market, By Route of Administrations:
- Oral
- Parenteral
- Others
Market, By End User:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
Market, By Distribution Channel:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Market, By Region:
- North America
- APAC
- Europe
- MEA
- South America
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global central nervous system therapeutics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Central Nervous System Therapeutics Market
4. Executive Summary
5. Voice of Customer
6. Global Central Nervous System Therapeutics Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Drug Class (Analgesics, Anesthetics, Anticonvulsants, Antiepileptics, Anti-Parkinson Agents, Others)
- 6.2.2. By Application (Neurovascular Diseases, Mental Health and Trauma, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer, Others)
- 6.2.3. By Route of Administration (Oral, Parenteral, Others)
- 6.2.4. By End Users (Hospitals, Clinics, Diagnostic Laboratories, Others)
- 6.2.5. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
- 6.2.6. By Company (2021)
- 6.2.7. By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
- 6.3. Product Market Map
7. North America Central Nervous System Therapeutics Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Drug Class
- 7.2.2. By Application
- 7.2.3. By Route of Administration
- 7.2.4. By End Users
- 7.2.5. By Distribution Channel
- 7.2.6. By Country (United States; Canada; Mexico)
- 7.3. North America: Country Analysis
- 7.3.1. United States Central Nervous System Therapeutics Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Drug Class
- 7.3.1.2.2. By Application
- 7.3.1.2.3. By Route of Administration
- 7.3.1.2.4. By End Users
- 7.3.1.2.5. By Distribution Channel
- 7.3.1.1. Market Size & Forecast
- 7.3.2. Canada Central Nervous System Therapeutics Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Drug Class
- 7.3.2.2.2. By Application
- 7.3.2.2.3. By Route of Administration
- 7.3.2.2.4. By End Users
- 7.3.2.2.5. By Distribution Channel
- 7.3.2.1. Market Size & Forecast
- 7.3.3. Mexico Central Nervous System Therapeutics Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Drug Class
- 7.3.3.2.2. By Application
- 7.3.3.2.3. By Route of Administration
- 7.3.3.2.4. By End Users
- 7.3.3.2.5. By Distribution Channel
- 7.3.3.1. Market Size & Forecast
- 7.3.1. United States Central Nervous System Therapeutics Market Outlook
8. Europe Central Nervous System Therapeutics Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Drug Class
- 8.2.2. By Application
- 8.2.3. By Route of Administration
- 8.2.4. By End Users
- 8.2.5. By Distribution Channel
- 8.2.6. By Country (France; Germany; UK; Italy; Spain)
- 8.3. Europe: Country Analysis
- 8.3.1. France Central Nervous System Therapeutics Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Drug Class
- 8.3.1.2.2. By Application
- 8.3.1.2.3. By Route of Administration
- 8.3.1.2.4. By End Users
- 8.3.1.2.5. By Distribution Channel
- 8.3.1.1. Market Size & Forecast
- 8.3.2. Germany Central Nervous System Therapeutics Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Drug Class
- 8.3.2.2.2. By Application
- 8.3.2.2.3. By Route of Administration
- 8.3.2.2.4. By End Users
- 8.3.2.2.5. By Distribution Channel
- 8.3.2.1. Market Size & Forecast
- 8.3.3. United Kingdom Central Nervous System Therapeutics Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Drug Class
- 8.3.3.2.2. By Application
- 8.3.3.2.3. By Route of Administration
- 8.3.3.2.4. By End Users
- 8.3.3.2.5. By Distribution Channel
- 8.3.3.1. Market Size & Forecast
- 8.3.4. Italy Central Nervous System Therapeutics Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Drug Class
- 8.3.4.2.2. By Application
- 8.3.4.2.3. By Route of Administration
- 8.3.4.2.4. By End Users
- 8.3.4.2.5. By Distribution Channel
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Spain Central Nervous System Therapeutics Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Drug Class
- 8.3.5.2.2. By Application
- 8.3.5.2.3. By Route of Administration
- 8.3.5.2.4. By End Users
- 8.3.5.2.5. By Distribution Channel
- 8.3.5.1. Market Size & Forecast
- 8.3.1. France Central Nervous System Therapeutics Market Outlook
9. Asia-Pacific Central Nervous System Therapeutics Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Drug Class
- 9.2.2. By Application
- 9.2.3. By Route of Administration
- 9.2.4. By End Users
- 9.2.5. By Distribution Channel
- 9.2.6. By Country (China; India; Japan; South Korea; Australia)
- 8.3 Asia-Pacific: Country Analysis
- 8.3.1 China Central Nervous System Therapeutics Market Outlook
- 8.3.1.1 Market Size & Forecast
- 8.3.1.1.1 By Value
- 8.3.1.2 Market Share & Forecast
- 8.3.1.2.1 By Drug Class
- 8.3.1.2.2 By Application
- 8.3.1.2.3 By Route of Administration
- 8.3.1.2.4 By End Users
- 8.3.1.2.5 By Distribution Channel
- 8.3.1.1 Market Size & Forecast
- 8.3.2 India Central Nervous System Therapeutics Market Outlook
- 8.3.2.1 Market Size & Forecast
- 8.3.2.1.1 By Value
- 8.3.2.2 Market Share & Forecast
- 8.3.2.2.1 By Drug Class
- 8.3.2.2.2 By Application
- 8.3.2.2.3 By Route of Administration
- 8.3.2.2.4 By End Users
- 8.3.2.2.5 By Distribution Channel
- 8.3.2.1 Market Size & Forecast
- 8.3.3 Japan Central Nervous System Therapeutics Market Outlook
- 8.3.3.1 Market Size & Forecast
- 8.3.3.1.1 By Value
- 8.3.3.2 Market Share & Forecast
- 8.3.3.2.1 By Drug Class
- 8.3.3.2.2 By Application
- 8.3.3.2.3 By Route of Administration
- 8.3.3.2.4 By End Users
- 8.3.3.2.5 By Distribution Channel
- 8.3.3.1 Market Size & Forecast
- 8.3.4 South Korea Central Nervous System Therapeutics Market Outlook
- 8.3.4.1 Market Size & Forecast
- 8.3.4.1.1 By Value
- 8.3.4.2 Market Share & Forecast
- 8.3.4.2.1 By Drug Class
- 8.3.4.2.2 By Application
- 8.3.4.2.3 By Route of Administration
- 8.3.4.2.4 By End Users
- 8.3.4.2.5 By Distribution Channel
- 8.3.4.1 Market Size & Forecast
- 8.3.5 Australia Central Nervous System Therapeutics Market Outlook
- 8.3.5.1 Market Size & Forecast
- 8.3.5.1.1 By Value
- 8.3.5.2 Market Share & Forecast
- 8.3.5.2.1 By Drug Class
- 8.3.5.2.2 By Application
- 8.3.5.2.3 By Route of Administration
- 8.3.5.2.4 By End Users
- 8.3.5.2.5 By Distribution Channel
- 8.3.5.1 Market Size & Forecast
- 8.3.1 China Central Nervous System Therapeutics Market Outlook
10. Middle East and Africa Central Nervous System Therapeutics Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Drug Class
- 10.2.2. By Application
- 10.2.3. By Route of Administration
- 10.2.4. By End Users
- 10.2.5. By Distribution Channel
- 10.2.6. By Country (UAE; Saudi Arabia; South Africa)
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Central Nervous System Therapeutics Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Drug Class
- 10.3.1.2.2. By Application
- 10.3.1.2.3. By Route of Administration
- 10.3.1.2.4. By End Users
- 10.3.1.2.5. By Distribution Channel
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Saudi Arabia Central Nervous System Therapeutics Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Drug Class
- 10.3.2.2.2. By Application
- 10.3.2.2.3. By Route of Administration
- 10.3.2.2.4. By End Users
- 10.3.2.2.5. By Distribution Channel
- 10.3.2.1. Market Size & Forecast
- 10.3.3. UAE Central Nervous System Therapeutics Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Drug Class
- 10.3.3.2.2. By Application
- 10.3.3.2.3. By Route of Administration
- 10.3.3.2.4. By End Users
- 10.3.3.2.5. By Distribution Channel
- 10.3.3.1. Market Size & Forecast
- 10.3.1. South Africa Central Nervous System Therapeutics Market Outlook
11. South America Central Nervous System Therapeutics Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Drug Class
- 11.2.2. By Application
- 11.2.3. By Route of Administration
- 11.2.4. By End Users
- 11.2.5. By Distribution Channel
- 11.2.6. By Country (Brazil; Argentina; Colombia)
- 11.3. South America: Country Analysis
- 11.3.1. Brazil Central Nervous System Therapeutics Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Drug Class
- 11.3.1.2.2. By Application
- 11.3.1.2.3. By Route of Administration
- 11.3.1.2.4. By End Users
- 11.3.1.2.5. By Distribution Channel
- 11.3.1.1. Market Size & Forecast
- 11.3.2. Argentina Central Nervous System Therapeutics Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Drug Class
- 11.3.2.2.2. By Application
- 11.3.2.2.3. By Route of Administration
- 11.3.2.2.4. By End Users
- 11.3.2.2.5. By Distribution Channel
- 11.3.2.1. Market Size & Forecast
- 11.3.3. Colombia Central Nervous System Therapeutics Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Type
- 11.3.3.2.2. By Drug Class
- 11.3.3.2.3. By Application
- 11.3.3.2.4. By Route of Administration
- 11.3.3.2.5. By End Users
- 11.3.3.2.6. By Distribution Channel
- 11.3.3.1. Market Size & Forecast
- 11.3.1. Brazil Central Nervous System Therapeutics Market Outlook
12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
- 14.1. Competition Outlook
- 14.2. Global Players Profiled (Leading Companies)
- 14.2.1. Eli Lilly and Company Ltd.
- 14.2.2. Merck & Co. Inc.
- 14.2.3. AstraZeneca PLC
- 14.2.4. Novartis AG
- 14.2.5. Teva Pharmaceutical Industries Ltd.
- 14.2.6. F. Hoffmann-La Roche AG
- 14.2.7. Biogen Inc.
- 14.2.8. Pfizer Inc.
- 14.2.9. GlaxoSmithKline PLC
- 14.2.10. Otsuka Holdings Co. Ltd.
- 14.2.11. Johnson & Johnson Services Inc.
- 14.2.12. Sanofi SA
- 14.2.13. Bristol Myers Squibb Pharmaceuticals Ltd.
- 14.2.14. Bayer AG
- 14.2.15. Amgen Inc.
15. Strategic Recommendations
16. About Us & Disclaimer
